Mechanistically, the early CRC-induced loss of local intestinal barrier integrity and the subsequent entry of microbial products into the tumor microenvironment relevantly trigger the activation of IL-23-producing intratumoral myeloid cells [125]. Here, IL23A is linked to neoplasm.